Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laure Elens

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
Pharmacogenomics|July 27, 2017
Advanced cancer pain: the search for genetic factors correlated with interindividual variability in opioid requirementMaja Matic, Joost Lm Jongen, Laure Elens, et al.
Pharmacogenomics|April 27, 2010
CYP3A5 and ABCB1 polymorphisms influence tacrolimus concentrations in peripheral blood mononuclear cells after renal transplantationArnaud Capron, Michel Mourad, Martine De Meyer, et al.
Antibiotics (Basel, Switzerland)|July 27, 2022
Population Pharmacokinetics of Temocillin Administered by Continuous Infusion in Patients with Septic Shock Associated with Intra-Abdominal Infection and Ascitic Fluid EffusionPerrin Ngougni Pokem, Xavier Wittebole, Christine Collienne, et al.
Therapeutic Drug Monitoring|April 19, 2020
Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug InteractionsLaure Elens, Loralie J Langman, Dennis A Hesselink, et al.
Clinical Chemistry|September 10, 2011
A new functional CYP3A4 intron 6 polymorphism significantly affects tacrolimus pharmacokinetics in kidney transplant recipientsLaure Elens, Rachida Bouamar, Dennis A Hesselink, et al.
Clinical Biochemistry|January 9, 2016
Quantification of darunavir and etravirine in human peripheral blood mononuclear cells using high performance liquid chromatography tandem mass spectrometry (LC-MS/MS), clinical application in a cohort of 110 HIV-1 infected patients and evidence of a potential drug-drug interactionLeïla Belkhir, Morgane De Laveleye, Bernard Vandercam, et al.
Scientific Reports|July 15, 2024
Effect of ABCB1 most frequent polymorphisms on the accumulation of bictegravir in recombinant HEK293 cell linesJulien De Greef, Mathilde Akue, Nadtha Panin, et al.
Molecular Diagnosis & Therapy|January 17, 2014
Lack of association of the p450 oxidoreductase *28 single nucleotide polymorphism with the lipid-lowering effect of statins in hypercholesterolemic patientsGeorgia Ragia, Vana Kolovou, Anna Tavridou, et al.
Fundamental & Clinical Pharmacology|July 1, 2020
Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatmentsFlorian Lemaitre, Caroline Solas, Matthieu Grégoire, et al.
Thrombosis Journal|November 21, 2018
Rivaroxaban plasma levels in patients admitted for bleeding events: insights from a prospective studyAnne-Laure Sennesael, Anne-Sophie Larock, Jonathan Douxfils, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
Pharmacogenomics|July 27, 2017
Advanced cancer pain: the search for genetic factors correlated with interindividual variability in opioid requirementMaja Matic, Joost Lm Jongen, Laure Elens, et al.
Pharmacogenomics|April 27, 2010
CYP3A5 and ABCB1 polymorphisms influence tacrolimus concentrations in peripheral blood mononuclear cells after renal transplantationArnaud Capron, Michel Mourad, Martine De Meyer, et al.
Antibiotics (Basel, Switzerland)|July 27, 2022
Population Pharmacokinetics of Temocillin Administered by Continuous Infusion in Patients with Septic Shock Associated with Intra-Abdominal Infection and Ascitic Fluid EffusionPerrin Ngougni Pokem, Xavier Wittebole, Christine Collienne, et al.
Therapeutic Drug Monitoring|April 19, 2020
Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug InteractionsLaure Elens, Loralie J Langman, Dennis A Hesselink, et al.
Clinical Chemistry|September 10, 2011
A new functional CYP3A4 intron 6 polymorphism significantly affects tacrolimus pharmacokinetics in kidney transplant recipientsLaure Elens, Rachida Bouamar, Dennis A Hesselink, et al.
Clinical Biochemistry|January 9, 2016
Quantification of darunavir and etravirine in human peripheral blood mononuclear cells using high performance liquid chromatography tandem mass spectrometry (LC-MS/MS), clinical application in a cohort of 110 HIV-1 infected patients and evidence of a potential drug-drug interactionLeïla Belkhir, Morgane De Laveleye, Bernard Vandercam, et al.
Scientific Reports|July 15, 2024
Effect of ABCB1 most frequent polymorphisms on the accumulation of bictegravir in recombinant HEK293 cell linesJulien De Greef, Mathilde Akue, Nadtha Panin, et al.
Molecular Diagnosis & Therapy|January 17, 2014
Lack of association of the p450 oxidoreductase *28 single nucleotide polymorphism with the lipid-lowering effect of statins in hypercholesterolemic patientsGeorgia Ragia, Vana Kolovou, Anna Tavridou, et al.
Fundamental & Clinical Pharmacology|July 1, 2020
Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatmentsFlorian Lemaitre, Caroline Solas, Matthieu Grégoire, et al.
Thrombosis Journal|November 21, 2018
Rivaroxaban plasma levels in patients admitted for bleeding events: insights from a prospective studyAnne-Laure Sennesael, Anne-Sophie Larock, Jonathan Douxfils, et al.
Pageof 9